Redmile Group, LLC Igm Biosciences, Inc. Transaction History
Redmile Group, LLC
- $822 Million
- Q2 2025
A detailed history of Redmile Group, LLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 2,952,131 shares of IGMS stock, worth $3.84 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
2,952,131
Previous 2,952,131
-0.0%
Holding current value
$3.84 Million
Previous $3.39 Million
2.59%
% of portfolio
0.4%
Previous 0.36%
Shares
6 transactions
Others Institutions Holding IGMS
# of Institutions
68Shares Held
15.1MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.1MShares$5.33 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.23 Million0.19% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.15 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY855KShares$1.11 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA767KShares$997,3000.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $37.7M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...